The global Epigenetic market is projected to reach US$ 11230 million by 2030.
Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
This report contains market size and forecasts of Epigenetic in Global, including the following market information:
Global Epigenetic Market Size 2025-2030, ($ millions)
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epigenetic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epigenetic Market, by Type, 2025-2030 ($ millions)
Global Epigenetic Market Segment Percentages, by Type
Reagents
Kits
Instruments
Enzymes
Services
Global Epigenetic Market, by Application, 2025-2030 ($ millions)
Global Epigenetic Market Segment Percentages, by Application
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
Global Epigenetic Market, By Region and Country, 2025-2030 ($ Millions)
Global Epigenetic Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Epigenetic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Epigenetic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Epigenetic Overall Market Size
2.1 Global Epigenetic Market Size: 2024 VS 2030
2.2 Global Epigenetic Market Size, Prospects & Forecasts: 2024-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Epigenetic Players in Global Market
3.2 Global Companies Epigenetic Product & Technology
4 Epigenetic Companies Profiles
4.1 Illumina
4.1.1 Illumina Company Summary
4.1.2 Illumina Business Overview
4.1.3 Illumina Epigenetic Product Offerings & Technology
4.1.4 Illumina Epigenetic R&D, and Plans
4.2 Qiagen
4.2.1 Qiagen Company Summary
4.2.2 Qiagen Business Overview
4.2.3 Qiagen Epigenetic Product Offerings & Technology
4.2.4 Qiagen Epigenetic R&D, and Plans
4.3 Abcam
4.3.1 Abcam Company Summary
4.3.2 Abcam Business Overview
4.3.3 Abcam Epigenetic Product Offerings & Technology
4.3.4 Abcam Epigenetic R&D, and Plans
4.4 Merck & Co
4.4.1 Merck & Co Company Summary
4.4.2 Merck & Co Business Overview
4.4.3 Merck & Co Epigenetic Product Offerings & Technology
4.4.4 Merck & Co Epigenetic R&D, and Plans
4.5 Sigma-Aldrich
4.5.1 Sigma-Aldrich Company Summary
4.5.2 Sigma-Aldrich Business Overview
4.5.3 Sigma-Aldrich Epigenetic Product Offerings & Technology
4.5.4 Sigma-Aldrich Epigenetic R&D, and Plans
4.6 New England Biolabs
4.6.1 New England Biolabs Company Summary
4.6.2 New England Biolabs Business Overview
4.6.3 New England Biolabs Epigenetic Product Offerings & Technology
4.6.4 New England Biolabs Epigenetic R&D, and Plans
4.7 Thermo Fisher Scientific
4.7.1 Thermo Fisher Scientific Company Summary
4.7.2 Thermo Fisher Scientific Business Overview
4.7.3 Thermo Fisher Scientific Epigenetic Product Offerings & Technology
4.7.4 Thermo Fisher Scientific Epigenetic R&D, and Plans
4.8 Diagenode
4.8.1 Diagenode Company Summary
4.8.2 Diagenode Business Overview
4.8.3 Diagenode Epigenetic Product Offerings & Technology
4.8.4 Diagenode Epigenetic R&D, and Plans
4.9 Active Motif
4.9.1 Active Motif Company Summary
4.9.2 Active Motif Business Overview
4.9.3 Active Motif Epigenetic Product Offerings & Technology
4.9.4 Active Motif Epigenetic R&D, and Plans
4.10 Roche Diagnostics
4.10.1 Roche Diagnostics Company Summary
4.10.2 Roche Diagnostics Business Overview
4.10.3 Roche Diagnostics Epigenetic Product Offerings & Technology
4.10.4 Roche Diagnostics Epigenetic R&D, and Plans
4.11 Eisai
4.11.1 Eisai Company Summary
4.11.2 Eisai Business Overview
4.11.3 Eisai Epigenetic Product Offerings & Technology
4.11.4 Eisai Epigenetic R&D, and Plans
4.12 Novartis
4.12.1 Novartis Company Summary
4.12.2 Novartis Business Overview
4.12.3 Novartis Epigenetic Product Offerings & Technology
4.12.4 Novartis Epigenetic R&D, and Plans
5 Sights by Region
5.1 By Region - Global Epigenetic Market Size, 2025 & 2030
5.2 By Region - Global Epigenetic Revenue, (2025-2030)
5.3 United States
5.3.1 Key Players of Epigenetic in United States
5.3.2 United States Epigenetic Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Epigenetic in Europe
5.4.2 Europe Epigenetic Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Epigenetic in China
5.5.2 China Epigenetic Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Epigenetic Market Size Markets, 2025 & 2030
6.2 Reagents
6.3 Kits
6.4 Instruments
6.5 Enzymes
6.6 Services
7 Sights by Application
7.1 By Application - Global Epigenetic Market Size, 2025 & 2030
7.2 Academic Research Institutes
7.3 Biotechnology Companies
7.4 Biopharmaceutical Companies
7.5 Diagnostic Companies
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Epigenetic Market Opportunities & Trends in Global Market
Table 2. Epigenetic Market Drivers in Global Market
Table 3. Epigenetic Market Restraints in Global Market
Table 4. Key Players of Epigenetic in Global Market
Table 5. Global Companies Epigenetic Product & Technology
Table 6. Illumina Company Summary
Table 7. Illumina Epigenetic Product Offerings
Table 8. Qiagen Company Summary
Table 9. Qiagen Epigenetic Product Offerings
Table 10. Abcam Company Summary
Table 11. Abcam Epigenetic Product Offerings
Table 12. Merck & Co Company Summary
Table 13. Merck & Co Epigenetic Product Offerings
Table 14. Sigma-Aldrich Company Summary
Table 15. Sigma-Aldrich Epigenetic Product Offerings
Table 16. New England Biolabs Company Summary
Table 17. New England Biolabs Epigenetic Product Offerings
Table 18. Thermo Fisher Scientific Company Summary
Table 19. Thermo Fisher Scientific Epigenetic Product Offerings
Table 20. Diagenode Company Summary
Table 21. Diagenode Epigenetic Product Offerings
Table 22. Active Motif Company Summary
Table 23. Active Motif Epigenetic Product Offerings
Table 24. Roche Diagnostics Company Summary
Table 25. Roche Diagnostics Epigenetic Product Offerings
Table 26. Eisai Company Summary
Table 27. Eisai Epigenetic Product Offerings
Table 28. Novartis Company Summary
Table 29. Novartis Epigenetic Product Offerings
Table 30. By Region? Global Epigenetic Revenue, (US$, Mn), 2025 & 2030
Table 31. By Region - Global Epigenetic Revenue, (US$, Mn), 2025-2030
Table 32. By Type ? Global Epigenetic Market Size, (US$, Mn), 2025 & 2030
Table 33. By Application? Global Epigenetic Market Size, (US$, Mn), 2025 & 2030
List of Figures
Figure 1. Epigenetic Segment by Type in 2030
Figure 2. Epigenetic Segment by Application in 2030
Figure 3. Global Epigenetic Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Epigenetic Market Size: 2024 VS 2030 (US$, Mn)
Figure 6. Global Epigenetic Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Epigenetic Revenue Market Share, 2025-2030
Figure 8. By Type - Global Epigenetic Revenue Market Share, 2025-2030
Figure 9. By Application - Global Epigenetic Revenue Market Share, 2025-2030
